Clinical Trial Update: A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women [Phase 1]

View source ↗

Summary

Phase 1 multiple-dose study evaluating skin irritation and sensitization from transdermal teriparatide in healthy postmenopausal women; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Forteo (teriparatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Postmenopausal | Phase 1 | Status: COMPLETED | Results posted: 2012-10-23